[1] Organization GWH. Depression and Other Common Mental Disorders: Global Health Estimates [J]. 2017, Licence: CC BY-NC-SA 3.0 IGO.
[2] Kim SY JS, Lim WJ. The Relationship between Serum Vitamin D Levels, C-Reactive Protein, and Anxiety Symptoms [J]. Psychiatry Investig, 2020, 17(4): 312-9. DOI:10.30773/pi.2019.0290
[3] Huang Y, Wang Y, Wang H, Liu Z, Yu X, Yan J, Yu Y, Kou C, Xu X, Lu J, Wang Z, He S, Xu Y, He Y, Li T, Guo W, Tian H, Xu G, Xu X, Ma Y, Wang L, Wang L, Yan Y, Wang B, Xiao S, Zhou L, Li L, Tan L, Zhang T, Ma C, Li Q, Ding H, Geng H, Jia F, Shi J, Wang S, Zhang N, Du X, Du X, Wu Y. Prevalence of mental disorders in China: a cross-sectional epidemiological study [J]. Lancet Psychiatry, 2019, 6(3): 211-24. DOI:10.1016/S2215-0366(18)30511-X
[4] Nasca C, Orlando R, Marchiafava M, Boldrini P, Battaglia G, Scaccianoce S, Matrisciano F, Pittaluga A, Nicoletti F. Exposure to predator odor and resulting anxiety enhances the expression of the alpha2 delta subunit of voltage-sensitive calcium channels in the amygdala [J]. J Neurochem, 2013, 125(5): 649-56. DOI:10.1111/j.1471-4159.2012.07895.x
[5] Shin SY, Baek NJ, Han SH, Min SS. Chronic administration of ketamine ameliorates the anxiety- and aggressive-like behavior in adolescent mice induced by neonatal maternal separation [J]. The Korean Journal of Physiology & Pharmacology, 2019, 23(1): DOI:10.4196/kjpp.2019.23.1.81
[6] Stein DJ, Vasconcelos MF, Albrechet-Souza L, Cereser KMM, de Almeida RMM. Microglial Over-Activation by Social Defeat Stress Contributes to Anxiety- and Depressive-Like Behaviors [J]. Front Behav Neurosci, 2017, 11(207. DOI:10.3389/fnbeh.2017.00207
[7] Assad N, Luz WL, Santos-Silva M, Carvalho T, Moraes S, Picanco-Diniz DLW, Bahia CP, Oliveira Batista EJ, da Conceicao Passos A, Oliveira K, Herculano AM. Acute Restraint Stress Evokes Anxiety-Like Behavior Mediated by Telencephalic Inactivation and GabAergic Dysfunction in Zebrafish Brains [J]. Sci Rep, 2020, 10(1): 5551. DOI:10.1038/s41598-020-62077-w
[8] Xialin Sun TZ, Yan Zhao, Enbo Cai, Hongyan Zhua and Shuangli Liu. Panaxynol Attenuates CUMS-induced Anxiety and Depressive-Like Behaviors via Regulating Neurotransmitters, Synapses and the HPA Axis in Mice [J]. Food Funct, 2020, 11(2): 1235-44. DOI:10.1039/c9fo03104a
[9] Wang Y, Li P, Zhang L, Fu J, Di T, Li N, Meng Y, Guo J, Zhao J. Stress aggravates and prolongs imiquimod-induced psoriasis-like epidermal hyperplasis and IL-1beta/IL-23p40 production [J]. J Leukoc Biol, 2020, DOI:10.1002/JLB.3MA0320-363RR
[10] Zhang ZS, Qiu ZK, He JL, Liu X, Chen JS, Wang YL. Resveratrol ameliorated the behavioral deficits in a mouse model of post-traumatic stress disorder [J]. Pharmacol Biochem Behav, 2017, 161(68-76. DOI:10.1016/j.pbb.2017.09.004
[11] Yang N, Ren Z, Zheng J, Feng L, Li D, Gao K, Zhang L, Liu Y, Zuo P. 5-(4-hydroxy-3-dimethoxybenzylidene)-rhodanine (RD-1)-improved mitochondrial function prevents anxiety- and depressive-like states induced by chronic corticosterone injections in mice [J]. Neuropharmacology, 2016, 105(587-93. DOI:10.1016/j.neuropharm.2016.02.031
[12] Sadiq Mahdi SA, Hasan Baksh, Abdulrahman Qareeballa, Bano Alsaleh, Faisal Falamarzi, Malak Alrabaani, Ali Alkalbani, Amer Kamal. Effect of Chronic Administration and Withdrawal of Caffeine on Motor Function, Cognitive Functions, Anxiety, and the Social Behavior of BLC57 Mice [J]. Int J Health Sci (Qassim), 2019, 13(2): 10-6.
[13] Zhang N, Zhang L, Feng L, Yao L. Cananga odorata essential oil reverses the anxiety induced by 1-(3-chlorophenyl) piperazine through regulating the MAPK pathway and serotonin system in mice [J]. Journal of Ethnopharmacology, 2018, 219(23-30. DOI:10.1016/j.jep.2018.03.013
[14] Nehlig A, Daval JL, Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects [J]. Brain Res Brain Res Rev, 1992, 17(2): 139-70. DOI:10.1016/0165-0173(92)90012-b
[15] de Rezende VB, Rosa DV, Comim CM, Magno LA, Rodrigues AL, Vidigal P, Jeromin A, Quevedo J, Romano-Silva MA. NCS-1 deficiency causes anxiety and depressive-like behavior with impaired non-aversive memory in mice [J]. Physiol Behav, 2014, 130(91-8. DOI:10.1016/j.physbeh.2014.03.005
[16] Onodera T, Sakudo A, Tsubone H, Itohara S. Review of studies that have used knockout mice to assess normal function of prion protein under immunological or pathophysiological stress [J]. Microbiol Immunol, 2014, 58(7): 361-74. DOI:10.1111/1348-0421.12162
[17] Mamiya T, Asanuma T, Kawai Y, Hasegawa Y, Nishimura A, Kumazawa T, Ukai M. Effects of soybean food pellets on m-CPP-induced anxiety model of mice [J]. Biol Pharm Bull, 2006, 29(7): 1498-500. DOI:10.1248/bpb.29.1498
[18] Mehmet Kurt SSB, Osman Kukula, Suleyman Celik, Yuksel Kesim. ANXIOLYTIC-LIKE PROFILE OF PROPOFOL, A GENERAL ANESTHETIC, IN THE PLUS-MAZE TEST IN MICE [J]. Pol J Pharmacol, 2003, 55(6): 973-7.
[19] Cui XY, Zhao X, Chu QP, Chen BQ, Zhang YH. Influence of diltiazem on the behavior of zolpidem-treated mice in the elevated-plus maze test [J]. J Neural Transm (Vienna), 2007, 114(2): 155-60. DOI:10.1007/s00702-006-0535-1
[20] Cornelio AM, Nunes-de-Souza RL. Anxiogenic-like effects of mCPP microinfusions into the amygdala (but not dorsal or ventral hippocampus) in mice exposed to elevated plus-maze [J]. Behav Brain Res, 2007, 178(1): 82-9. DOI:10.1016/j.bbr.2006.12.003
[21] Zhang N, Zhang L, Feng L, Yao L. Cananga odorata essential oil reverses the anxiety induced by 1-(3-chlorophenyl) piperazine through regulating the MAPK pathway and serotonin system in mice [J]. J Ethnopharmacol, 2018, 219(23-30. DOI:10.1016/j.jep.2018.03.013
[22] Gupta D, Radhakrishnan M, Thangaraj D, Kurhe Y. Pharmacological evaluation of novel 5-HT3 receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery [J]. J Pharm Bioallied Sci, 2015, 7(2): 103-8. DOI:10.4103/0975-7406.154429
[23] Daniel Benjamin HLLRM. The effects of 5-HT1B characterizing agents in the mouse elevated plus-maze [J]. Life Sci, 1990, 47(3): 195-203.
[24] Takayoshi MAMIYA TA, Yoshiaki KAWAI, Yuya HASEGAWA, Atsuhisa NISHIMURA, Toshihiko KUMAZAWA, Makoto UKAIa. Effects of Soybean Food Pellets on m-CPP-Induced Anxiety Model of Mice [J]. Biol Pharm Bull, 2006, 29(7): 1498-500.
[25] R S Kahn SW. m-Chlorophenylpiperazine as a probe of serotonin function [J]. Biol Psychiatry, 1991, 30(11): 1139-66.
[26] Rurak A, Melzacka M. Effect of dosage and route of administration of trazodone on cerebral concentration of 1-m-chlorophenylpiperazine in rats. Kinetics of trazodone biotransformation in rats [J]. Pol J Pharmacol Pharm, 1983, 35(3): 241-7.
[27] Kreiss DS, De Deurwaerdere P. Purposeless oral activity induced by meta-chlorophenylpiperazine (m-CPP): Undefined tic-like behaviors? [J]. J Neurosci Methods, 2017, 292(30-6. DOI:10.1016/j.jneumeth.2017.05.007
[28] Tucci MC, Dvorkin-Gheva A, Johnson E, Wong M, Szechtman H. 5-HT2A/C receptors do not mediate the attenuation of compulsive checking by mCPP in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD) [J]. Behav Brain Res, 2015, 279(211-7. DOI:10.1016/j.bbr.2014.11.017
[29] Khaliq S, Haider S, Saleem S, Memon Z, Haleem DJ. Influence of serotonergic 5-HT2C receptor antagonist mesulergine in the reversal of memory deficits induced by mCPP [J]. J Coll Physicians Surg Pak, 2012, 22(2): 75-9. DOI:02.2012/JCPSP.7579
[30] Charney DS, Woods SW, Goodman WK, Heninger GR. Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects [J]. Psychopharmacology (Berl), 1987, 92(1): 14-24. DOI:10.1007/BF00215473
[31] Wood MD. Therapeutic potential of 5-HT2C receptor antagonists in the treatment of anxiety disorders [J]. Curr Drug Targets CNS Neurol Disord, 2003, 2(6): 383-7. DOI:10.2174/1568007033482698
[32] Campbell BM, Merchant KM. Serotonin 2C receptors within the basolateral amygdala induce acute fear-like responses in an open-field environment [J]. Brain Research, 2003, 993(1-2): 1-9. DOI:10.1016/s0006-8993(03)03384-5
[33] Fiorella D, Helsley S, Rabin RA, Winter JC. 5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine [J]. Psychopharmacology (Berl), 1995, 122(3): 237-43. DOI:10.1007/BF02246545
[34] Overstreet DH, Knapp DJ, Breese GR, Diamond I. A selective ALDH-2 inhibitor reduces anxiety in rats [J]. Pharmacol Biochem Behav, 2009, 94(2): 255-61. DOI:10.1016/j.pbb.2009.09.004
[35] Fox JH, Hammack SE, Falls WA. Exercise is associated with reduction in the anxiogenic effect of mCPP on acoustic startle [J]. Behav Neurosci, 2008, 122(4): 943-8. DOI:10.1037/0735-7044.122.4.943
[36] Takamatsu H, Noda A, Murakami Y, Tatsumi M, Ichise R, Nishimura S. A PET study after treatment with an anxiety-provoking agent, m-chlorophenyl-piperazine, in conscious rhesus monkeys [J]. J Nucl Med, 2003, 44(9): 1516-21.
[37] Jones N, Duxon MS, King SM. Ethopharmacological analysis of the unstable elevated exposed plus maze, a novel model of extreme anxiety: predictive validity and sensitivity to anxiogenic agents [J]. Psychopharmacology (Berl), 2002, 161(3): 314-23. DOI:10.1007/s00213-002-1029-y